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This paper describes and compares two methods for estimat-
ing the variance function associated with iTRAQ (isobaric tag for
relative and absolute quantitation) isotopic labeling in quantitative
mass spectrometry based proteomics. Measurements generated by the
mass spectrometer are proportional to the concentration of peptides
present in the biological sample. However, the iTRAQ reporter sig-
nals are subject to errors that depend on the peptide amounts. The
variance function of the errors is therefore an essential parameter for
evaluating the results, but estimating it is complicated, as the number
of nuisance parameters increases with sample size while the number
of replicates for each peptide remains small. Two experiments that
were conducted with the sole goal of estimating the variance function
and its stability over time are analyzed, and the resulting estimated
variance function is used to analyze an experiment targeting aber-
rant signaling cascades in cells harboring distinct oncogenic muta-
tions. Methods for constructing conservative p-values and confidence
intervals are discussed.
1. Introduction. Improvements in mass spectrometer resolution, accu-
racy and sensitivity coupled with the development of increasingly sophisti-
cated algorithms for protein identification from spectra have resulted in mass
spectrometry (MS) becoming the tool of choice in large scale proteomics re-
search. Typically, the mass spectrometer is used to measure short portions
of the proteins called peptides. These are subjected to a process called tan-
dem mass spectrometry (MS/MS) which ultimately yields a mass spectrum
containing peaks which correspond to the primary amino acid sequence and
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Fig. 1. Left: scatterplots of Yi1 versus Yi2 in the March experiment. Right: pointwise
estimates of mean and variance and different models for the variance.
enable the identification of peptides. When samples are labeled with iTRAQ
(isobaric tag for relative and absolute quantitation) stable isotope reagents,
the MS/MS spectra also contain peaks at predefined masses, whose intensi-
ties provide a relative measure of the peptide abundance in a set of samples.
A single experiment can yield tens of thousands of spectra identifying thou-
sands of peptides belonging to thousands of proteins. Analysis of samples
from different sources, for example, cells expressing different mutations in
a known oncogene versus the wild-type (e.g., nontransforming) counterpart
can provide insight as to the mechanisms by which specific genetic lesions
manifested in the same protein drive a malignant phenotype. A workflow
diagram and a brief explanation of the iTRAQ technique are given in Part
A of the supplemental article [Mandel et al. (2013)]; for a detailed discussion
on MS techniques see Eckel-Passow et al. (2009).
In an experiment conducted in March 2009 and described below, Zhang
et al. (2010) applied the iTRAQ protocol using two different labels for the
same biological sample. The experiment yielded 2174 pairs of measurements
corresponding to the amounts of 2174 peptides in the sample. The left panel
of Figure 1 depicts the data1 (on a logarithmic scale) and clearly shows that
the variance of peak intensity measurements is nonconstant and depends on
the mean. This variance should be estimated for better understanding of
the results of the MS analysis and to enable statistical inference about the
peptide amounts. The right panel of Figure 1 displays the mean of each pair
against its variance together with several estimates of the variance function
described in Section 2.3.
1Pairs with exactly the same realized value were excluded from the analysis; there were
two such peptides.
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The purpose of the current paper is twofold: first, to estimate the vari-
ance function related to observations obtained by the common technique of
iTRAQ stable isotope labeling [Ross et al. (2004), Aggarwal, Choe and Lee
(2006)], which provides measurements of the relative amounts of peptides
from two different biological samples in a single experimental run; and sec-
ond, to construct confidence intervals for the abundance of a given peptide
in a biological sample and to the ratio of two abundances under different
conditions (e.g., cancer and wild type cells) using the estimated variance
function, and to calculate p-values for the hypothesis of equality in peptide
amounts in two independent samples.
Models that define the variance as a function of the mean have been stud-
ied intensively in the framework of heteroscedastic regression, where differ-
ent estimation techniques have been suggested [e.g., Davidian and Carroll
(1987)]. However, in MS, the variance function depends on the unknown
peptide amount and the estimation problem is much more involved. A sim-
ilar problem arises in certain immunoassay studies where few or no stan-
dard concentrations are available [Raab (1981), Sadler and Smith (1986),
O’Malley, Smith and Sadler (2008)], and in the evolving area of microarray
mRNA expression analysis [Carroll and Wang (2008), Wang, Ma and Car-
roll (2009), Fan, Feng and Niu (2010)]. Unlike immunoassay and microarray,
labeled MS data can contain as few as two measurements of each peptide
relative quantity and, therefore, analysis requires a special experiment for
estimating the variance function.
In a previous study, Zhang et al. (2010) suggest a novel controlled exper-
iment for the estimation of the variance function in the iTRAQ protocol.
Using the standard workflow, they held the sample constant by generating
pairs of iTRAQ intensities from identical biological samples. Under this ex-
periment, it is reasonable to assume that the iTRAQ labels are interchange-
able in their error characteristics since labeled samples are mixed before
processing and, therefore, the difference within pairs of such measurements
are entirely attributable to the measurement error of the instrument itself.
Two controlled experiments were conducted in January and March of 2009
with the sole goal of estimating the variance function [Zhang et al. (2010)].
A separate experiment was conducted to explore differences observed be-
tween wild-type and cancer cells expressing distinct mutations of the same
oncogenic kinase (FLT3); this experiment relied on the variance function es-
timated in the controlled study. The motivation for our current study arises
from these past experiments, and below we describe in detail the mathemat-
ical problem, suggest statistical methods to tackle it and apply them to the
three data sets mentioned above.
In Section 2 we present a naive method for estimating the variance func-
tion employed by Zhang et al. and explore its validity. We show that the
method works well when the error terms are typically small, as is the case
in the instrument explored by Zhang et al. (2010), but may yield biased
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estimators for the variance function in other situations. We then suggest an
alternative mixture model approach for estimating the variance function and
prove its consistency. In Section 3 we use the estimated variance function
for interval estimation of the ratio of peptides across two different biological
conditions, and we apply the method to iTRAQ-based MS analysis that is in-
tended to decipher the oncogenic potential of two different clinically relevant
mutations in the FLT3 receptor tyrosine kinase. Section 4 discusses testing
of the hypothesis that the amounts of peptides in two biological samples are
equivalent. The properties of the estimation approaches are investigated in
Section 5 by simulation. Section 6 completes the paper with some remarks.
2. Estimation of the variance function.
2.1. The model. Consider a controlled iTRAQ experiment that quanti-
fies N peptides. Let Yi1, Yi2 denote two measures of intensity of peptide i
(on a logarithmic scale) having an unknown mean µi. Assume that (Yi1, Yi2)
(i= 1, . . . ,N ) are independent following the model:
Yij ∼N(µi, h(θ,µi)), j = 1,2, independent,(1)
where θ is a vector of unknown variance parameters, and h(θ,µ) is a known
positive function, such as the power function θ1µ
θ2 or the exponential func-
tion eθ1+θ2µ. In problems where µ1, . . . , µN are known or are modeled by
a small number of auxiliary variables, standard techniques for estimating
heteroscedastic regression models apply [e.g., Davidian and Carroll (1987)].
However, this is not the case in MS data where µ1, . . . , µN are unknown
nuisance parameters.
Klawonn, Hundertmark and Ja¨nsch (2006) and Hundertmark et al. (2009)
developed an EM algorithm that maximizes over µ1, . . . , µN and θ the likeli-
hood corresponding toN independent observations, (yi1, yi2), from model (1):
N∏
i=1
{2πh(θ,µi)}−1 exp
{
−(yi1 − µi)
2 + (yi2 − µi)2
2h(θ,µi)
}
.(2)
However, since the number of nuisance parameters increases with sample
size, the maximum likelihood approach may provide biased estimators. The
bias is readily seen in the classical example by Neyman and Scott (1948)
of the one-parameter homoscedastic model h(θ,µ) = θ. The maximum like-
lihood estimator for θ under this model is N−1
∑
i(Yi1 − Yi2)2/4 having ex-
pectation θ/2, hence it converges to half the true variance. Thus, although
the model is parametric, alternatives to the maximum likelihood technique
should be employed.
2.2. The MACL approach of Sadler and Smith. Motivated by immunoas-
say data, Raab (1981) suggests to modify the likelihood (2) by multiplying
the contribution of each of the pairs (Yi1, Yi2) by h
1/2(θ,µi), and then to
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maximize the modified likelihood with respect to µ1, . . . , µN and θ. Raab
shows by simulation that the standard maximum likelihood estimator is bi-
ased, but the modified estimator performs reasonably well. Raab’s method is
computer intensive, as it requires the estimation of all nuisance parameters.
Sadler and Smith (1986) estimate θ by maximizing Raab’s modified like-
lihood at the point µi = Y¯i := (Yi1 + Yi2)/2 (i= 1, . . . ,N):
θˆ = argmax
θ
N∏
i=1
1
4π2
√
h(θ, Y¯i)
exp{−S2i /2h(θ, Y¯i)},(3)
where S2i := (Yi1 − Y¯i)2 + (Yi2 − Y¯i)2 = (Yi1 − Yi2)2/2. This approach, called
maximum approximate conditional likelihood (MACL) by Sadler and Smith,
reduces the estimation task to solving a small set of nonlinear equations. The
resulting estimating equations under the normal model are therefore
N∑
i=1
∂h(θ, Y¯i)/∂θj
h2(θ, Y¯i)
{S2i − h(θ, Y¯i)}= 0.
For example, for the model h(θ,µ) = exp(θ1+θ2µ), the estimating equations
reduce to
1−N−1
N∑
i=1
S2i exp(−θ1 − θ2Y¯i) = 0,(4)
N−1
N∑
i=1
Y¯i −N−1
N∑
i=1
Y¯iS
2
i exp(−θ1 − θ2Y¯i) = 0,(5)
and can be easily solved by standard optimization algorithms using, for ex-
ample, the R function optim [R Development Core Team (2011)]. As pointed
out by Sadler and Smith, the solution for (3) can be obtained by an iterative
reweighted least squares algorithm.
We applied the MACL approach to the January (N = 2144) and March
(N = 2174) experiments described in Section 1 using the functional form
h(θ,µ) = exp(θ1 + θ2µ) and obtained the estimates θˆ = (4.89,−0.935) and
θˆ = (4.89,−0.925), respectively.2 The similarity of the two estimated vari-
ance functions is remarkable, suggesting that the between-study variability
is small. This is a very important finding, as the variance function can be
estimated in a control experiment and be applied to data obtained in inde-
pendent experiments on the same instrument. We finally pooled the data
together and obtained an overall MACL estimate of θˆ = (4.86,−0.927).
Neither Raab nor Sadler and Smith provide sound theoretical justification
for their methods, but explore them in several special relevant cases. In
2Data and R codes can be accessed as project syn310406 on the Sage Bionetworks
Synapse system (http://synapse.sagebase.org).
6 MANDEL, ASKENAZI, ZHANG AND MARTO
general, the expectation of the estimating equations differs from 0, hence,
the estimators of the variance function are, in general, inconsistent. This is
shown in Appendix A and is illustrated by simulation in Section 5. However,
Appendix A suggests that the bias is small when the variance (for all µi)
is small, because in such circumstances Y¯i is a good estimator for µi, even
though it is based on only two observations. Recently, Wang, Ma and Carroll
(2009) studied variance functions for microarray experiments and showed
a similar inconsistency problem of estimators obtained by the method of
moments.
2.3. A mixture model. A possible strategy to deal with the inconsistency
of the MACL approach is to impose additional reasonable assumptions on
the nuisance parameters. We consider the model
Yij|µi ∼N(µi, h(θ,µi)), j = 1,2, independent,
(6)
µi ∼G0, i= 1, . . . ,N, independent,
where (i) the support of G0 is in the segment [a, b], that is, P (a≤ µi ≤ b) = 1,
(ii) the variance is bounded, that is, α< h(θ,µ)< β for all µ in the support of
G0 for some 0<α< β <∞, (iii) h(θ,µ) is continuous on [a, b] and identifies
θ, that is, knowing h(θ,µ) on the support of G0 implies knowledge of θ.
The assumptions on h are satisfied by most practical models. The rea-
son for bounding G0 and the choice of the values a and b are discussed in
Section 3. To see the importance of the identifiability assumption, consider
the model h(θ,µ) = exp(θ1 + θ2µ) and a degenerate G0 that assigns all the
mass to some µ0. In such a model, exp(θ1 + θ2µ0) is identifiable, but the
pair (θ1, θ2) is not.
Theorem 1. Under model (6) and the assumptions following it, the
maximum likelihood estimator of (θ,G0) is consistent.
The proof, which is sketched in Appendix B, is based on the seminal paper
by Kiefer and Wolfowitz (1956) who prove the consistency of the maximum
likelihood estimator in mixture models such as (6). A recent application of
mixture models for variance estimation in microarray analysis can be found
in Wang, Ma and Carroll (2009), though they suggest a different estimation
strategy for θ.
Several algorithms for deriving the maximum likelihood estimator of a
mixture model have been suggested in the literature [see, e.g., Bo¨hning
(1999)]. Here we estimate θ and G0 by employing the EM algorithm, treat-
ing (Yi1, Yi2, µi) as the complete data on the ith peptide. One strategy for
estimating G0 is to restrict the search to distributions supported on a fine
grid and to find the maximum likelihood among these distributions. In the
current problem, the variance becomes small for large values of µ and using
a simple grid may lead to data points which are too far (in terms of stan-
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dard deviations) from all support points. We found that defining the support
points of G0 as a function of the variance performed better than using a sim-
ple grid. Thus, we first obtained an initial estimate of the variance function
using, for example, the MACL approach, and then restricted the distance
between two support points to be at most d standard deviations according
to the estimated function. Specifically, let θ˜ be an initial estimate for θ,
and define the maximal support point to be µJ = b, the second to maximal
to be µJ−1 = µJ − d
√
h(θ˜, µJ) and recursively µj−1 = µj − d
√
h(θ˜, µj). The
selected points of support depend on the initial estimate of the variance
function and can be updated as part of the algorithm, though in our ex-
perience, this update made no significant improvement when using d= 1/4.
Once the support points for G0 are determined, the EM algorithm is applied
to estimate θ and G0. The algorithm is quite standard and its description
is detailed in Appendix C.
We fit the following three forms for h(θ,µ) that have been suggested
in the literature3: exp(θ1)µ
θ2 , exp(θ1 + θ2µ) and exp(θ1 + θ2µ) + exp(θ3).
The right panel of Figure 1 presents estimates of these three functions on
a scatter diagram of Y¯i = (Yi1 + Yi2)/2 against S
2
i = (Yi1 − Yi2)2/2. The X-
axis is a naive estimate of the mean of each pair, µi, and the Y-axis is a
naive estimate of the variance. All three models give similar results in most
of the range with some deviation for very small values of µ. A loess fit,
presented in the figure by the dotted line, is quite close to the functional
form h(θ,µ) = exp(θ1 + θ2µ) originally suggested by Zhang et al. (2010).
This latter model is used throughout this paper.
Applying the EM approach using the functional form h(θ,µ) = exp(θ1 +
θ2µ), we obtained the estimates θˆ = (4.91,−0.929) and θˆ = (4.96,−0.944)
based on the January and March experiments, respectively. The estimates
are very similar to the estimates obtained by the MACL approach. We then
pooled the data from the two experiments together and obtained our final
estimate, θˆ = (4.84,−0.927). The corresponding estimate of G0 is displayed
in the supplemental article [Mandel et al. (2013)]. Initial values for the EM
algorithm were obtained by the MACL approach. Starting the algorithm
from different points resulted in essentially the same estimate (details are
provided in the supplementary materials).
3. Confidence intervals. Having estimated the variance function, confi-
dence intervals for various parameters of interest can be constructed based
on data from a new experiment that compares different biological samples.
We construct frequentist confidence intervals that are based on the estimate
3Data and R codes can be accessed as project syn310406 on the Sage Bionetworks
Synapse system (http://synapse.sagebase.org).
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θˆ of θ under model (6), but do not use the estimate of the mixing distribution
G0. We take this approach since the variance function is a stable character-
istic of the mass spectrometer, whereas G0 depends on the biological sample
and may differ from sample to sample.
3.1. Confidence intervals for µ. It is of interest to attach a measure of
uncertainty to the observed intensity or to report a range rather than one
value for each peptide. This section discusses the construction of 1−α confi-
dence intervals for the peptide amount, µ, based on one observation Y from
the model Y ∼ N(µ,h(θ,µ)); the next section deals with the construction
of confidence sets for the relative abundance of a peptide in two different
samples.
Similar to the MACL approach for estimation, construction of confidence
intervals can be simplified by plugging an estimate of µ in h(θ,µ). Thus,
a naive confidence interval is constructed by Y ± z1−α/2
√
h(θˆ, Y ), where
zα is the α quantile of the standard normal distribution. This method is
expected to perform reasonably well only in cases were the variance is small
and changes slowly with µ.
An exact 1 − α confidence set for µ can be constructed using the piv-
otal quantity gY (µ) = (Y − µ)2/h(θ,µ). This interval is defined as Cα =
{µ :gY (µ)≤ χ1,1−α}, where χdf,α is the α quantile of the chi-squared distri-
bution with df degrees of freedom.
For the model h(θ,µ) = exp(θ1 + θ2µ), this set can be easily found by a
bisection search using the following observations:
(1) gY (Y ) = 0 is a local minimum.
(2) For θ2 < 0, µ
∗ = Y +2/θ2 is a local maximum of gY (µ), with gY (µ
∗) =
4θ−22 e
−(2+θ1+θ2Y ).
We thus obtain the following properties of the confidence procedure:
• If gY (µ∗) ≤ χ1−α, then the confidence set is a one-sided interval of the
form (−∞, r1).
• If gY (µ∗) > χ1−α, then the confidence set is a union of two intervals,
(−∞, r1)∪ (l2, r2), where r1 < µ∗ < l2 < Y < r2.
This nonstandard shape of the confidence set reflects the fact that a realiza-
tion y is likely either when µ is close to y or when µ is much smaller than
y and the variance of the measurement is very large. Often, the range of
µ is a priori bounded so that values smaller than r1 do not belong to the
parameter space, and the confidence set is always an interval.
Since the parameter θ is unknown, a consistent estimator based on the
mixture approach is plugged in to generate confidence intervals with an
approximate level 1−α.
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3.2. Confidence intervals for µ1−µ2. Let Y1 ∼N(µ1, h(θ,µ1)) and Y2 ∼
N(µ2, h(θ,µ2)) be the log intensities of the same peptide obtained by the
iTRAQ protocol under two different conditions, and assume that Y1 and Y2
are independent conditionally on µ1 and µ2. We consider the construction
of a confidence set for µ1 − µ2, which is the parameter of primary interest
in many quantitative MS studies.
As in the one-parameter case, a naive confidence interval for µ1 − µ2
can be obtained by plugging Y1 and Y2 into the variance term: Y1 − Y2 ±
z1−α/2
√
h(θˆ, Y1) + h(θˆ, Y2). However, such intervals may be anti-conservative,
as the estimator Yi for µi is inconsistent, and hence so is the estimator
h(θˆ, Yi) for h(θ,µi).
A direct and a relatively simple way of calculating conservative intervals
is by Bonferroni correction, that is, by first constructing 1−α/2 intervals for
µ1 and for µ2, as described in the previous section, and then calculating the
minimum and maximum differences of the two intervals. However, a more
direct construction uses the reparametrization ν1 = µ1−µ2 and ν2 = µ1+µ2.
Let
gY1−Y2(ν1, ν2) =
Y1 − Y2 − ν1√
h(θ, (ν2 − ν1)/2) + h(θ, (ν2 + ν1)/2)
and
gY1+Y2(ν1, ν2) =
Y1 + Y2− ν2√
h(θ, (ν2 − ν1)/2) + h(θ, (ν2 + ν1)/2)
,
then (gY1−Y2(ν1, ν2), gY1+Y2(ν1, ν2)) has a bivariate standard normal distri-
bution with correlation
ρ(ν1, ν2) = {h(θ, (ν2+ ν1)/2)− h(θ, (ν2− ν1)/2)}
/{h(θ, (ν2 − ν1)/2) + h(θ, (ν2+ ν1)/2)}.
Thus,
gY1,Y2(ν1, ν2) = (gY1−Y2(ν1, ν2), gY1+Y2(ν1, ν2))
×
(
1 ρ(ν1, ν2)
ρ(ν1, ν2) 1
)
−1(
gY1−Y2(ν1, ν2)
gY1+Y2(ν1, ν2)
)
has a χ2(2) distribution and can serve as a pivot for constructing confidence
regions. Specifically,
CY1,Y2(ν1, ν2) = {(ν1, ν2) :gY1,Y2(ν1, ν2)≤ χ2,1−α}(7)
is an exact 1−α confidence region for (ν1, ν2) and, therefore, {ν1 : (ν1, ν2) ∈
CY1,Y2(ν1, ν2),−∞< ν2 <∞} is a conservative confidence set for ν1.
3.3. An application to the iTRAQ protocol. In this section we analyze
data from the two control experiments mentioned in Section 1. As the two
biological samples in these experiments were identical, µi1 − µi2 = 0 for all
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Fig. 2. 95% confidence regions for the pair (ν1, ν2) constructed for two data points: (8,9)
(left) and (7.5,8) (right).
peptides i= 1, . . . ,N . In order to evaluate the performance of our confidence
intervals, we used the parameters’ estimates from one experiment to con-
struct 95% level confidence intervals for the difference of peptide abundances
in the other experiment, and calculated the proportion of intervals that did
not cover 0, the true difference.
As in the uni-parameter case, the confidence set for (ν1, ν2) is not neces-
sarily a connected set and the resulting confidence set for ν1 is not always
an interval. Figure 2 demonstrates the shape of the confidence region for
the pairs (Y1, Y2) = (8,9) and (Y1, Y2) = (7.5,8). The X and Y axes are, re-
spectively, ν1 and ν2, and the confidence sets are the shaded areas. The
figure reveals that without restricting the parameter space of µ (hence the
parameter space of ν1), the confidence interval for ν1 comprises all of the
real line and is noninformative. We therefore assumed that µ ∈ [7.3,13.9],
where the limits were determined from typically observed values as well as
the expected range of the intensity values. This decision restricts the values
of ν1 and ν2 to the large parallelograms depicted in Figure 2, and enables
the construction of informative confidence intervals. The smaller parallelo-
grams represent confidence sets obtained by Bonferroni correction applied
to univariate confidence intervals for µ1 and for µ2.
Using estimates from the January data, we calculated confidence intervals
for ν1 for peptides in the March experiment by (7), Bonferroni correction
and the naive approach, and found that, respectively, 18 (0.8%), 1 (0.05%)
and 86 (3.96%) of the 2174 intervals did not include the true parameter
ν1 = 0. The corresponding numbers for the 2144 peptides in the January
experiments using estimates from the March data are 47 (2.19%), 8 (0.4%)
and 106 (4.94%). This exercise suggests that interval (7) is better than the
Bonferroni interval, but is still conservative. The naive approach performs
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Table 1
95% confidence intervals for the ratio of phosphopeptide quantity across two experimental
conditions using the conservative and the naive approaches
Phosphopeptide FLT3-D835Y FLT3-ITD CI CI naive
VLPQDKEpYYK 10.21 10.78 (0.41,0.76) (0.44,0.72)
GQESEpYGNITYPPAVR 13.62 11.89 (5.05,6.36) (5.11,6.22)
HKEEVpYENVHSK 11.19 9.92 (2.66,5.05) (2.76,4.59)
pYKNILPFDHSR 10.83 9.80 (2.03,4.10) (2.12,3.69)
AVDGpYVKPQIK 11.45 13.36 (0.13,0.17) (0.13,0.17)
surprisingly well in our experiment, but, in general, its theoretical coverage
probability is not controlled. Further research is needed to understand this
phenomenon.
3.4. An application to cancer phosphoproteomics. Zhang et al. (2010)
used iTRAQ labeling to study a key modification to proteins called phos-
phorylation, which is important in cell signaling, and is often deregulated in
cancer cells. Their study focused on aberrant signaling arising from onco-
genic FLT3 mutations in acute myeloid leukemia. In particular, they moni-
tored a key, subcomponent of signal transduction, namely, protein tyrosine
phosphorylation, in order to obtain a global understanding of the onco-
genic potential of two clinically identified FLT3 mutants (FLT3-D835Y and
FLT3-ITD). Both FLT3 mutants induce constitutive signaling even in the
absence of proper external cues, which results in uncontrolled cell prolifera-
tion, a hallmark of cancer development [Blume-Jensen and Hunter (2001)].
Since receptor tyrosine kinases are often constitutively active in cancer cells,
it is not surprising that a large proportion of downstream phosphorylation
events diverge from a 1:1 value (measured relative to a control cell line),
effectively eliminating the possibility of deriving a variance function from
the experimental data themselves.
Based on the mixture model results of the pooled control experiments, we
calculated 95% confidence intervals for the ratio of phosphopeptides men-
tioned explicitly in the figures of Zhang et al.; these are reported in Ta-
ble 1. For comparison, we calculated confidence intervals based on a naive
approach mentioned in Section 3.2. Using the intensity-dependent variance
function described in this paper, as opposed to a constant cutoff point often
used in the literature, subtle changes in phosphorylation levels can be found
(e.g., peptide VLPQDKEpYYK). Such ratios can be considered statistically
significant despite being smaller than the typical cutoff of 2:1. This in turn
suggests that experiments can be designed to explore phosphorylation under
physiological conditions, unlike many current experimental designs where ar-
tificial or extreme environments are used in order to amplify the observed
ratios.
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4. Hypothesis testing.
4.1. Calculation of p-values. For a given peptide, consider testing the hy-
pothesis H0 :µ1 = µ2 = µ versus the two-sided alternative H1 :µ1 6= µ2. The-
oretically, this can be done by inverting the confidence intervals discussed
in the previous section. However, for calculating p-values, this inversion is
computationally difficult and the current section explores an alternative ap-
proach.
As before, let Y1 ∼N(µ1, h(θ,µ1)) and Y2 ∼N(µ2, h(θ,µ2)) be indepen-
dent, then Y1 − Y2 ∼ N(µ1 − µ2, h(θ,µ1) + h(θ,µ2)) and a reasonable test
may compare
(Y1 − Y2)2
2h(θ,µ)
(8)
to the chi-squared distribution with one degree of freedom. However, (8)
contains the unknown parameters θ and µ, and hence is not a legitimate test
statistic. As in the construction of confidence intervals, a naive p-value can
be calculated by replacing the denominator of (8) with 2h(θˆ, (Y1 + Y2)/2).
Although it is reasonable to replace θ with its consistent estimator θˆ, the
average (Y1 + Y2)/2 is an inconsistent estimator for µ, possibly leading to
an anti-conservative p-value.
As in other statistical problems involving nuisance parameters, an asymp-
totically conservative p-value is obtained by
sup
µ∈[a,b]
P (Z2 > (y1 − y2)2/2h(θˆ, µ)),
where y1 and y2 are the realized values and Z
2 is a χ2(1) random variable.
This approach is simple and easy to implement but results in an overly
conservative p-value. We therefore suggest to employ the approach of Berger
and Boos (1994), where the p-value is calculated by maximization over a
confidence interval for the nuisance parameter. Specifically, let Cβ be a 1−β
level confidence interval for µ, obtained in a way similar to that presented
in Section 3.1, then we define our p-value as
sup
µ∈Cβ
P (Z2 > (y1 − y2)2/2h(θˆ, µ)) + β.(9)
The choice of β depends on the context. If a univariate hypothesis is tested
with a significant level of 5%, then β = 0.001 is usually a good choice. How-
ever, if a Bonferroni correction is needed, then β must be much smaller, as
p-value> β by construction.
4.2. Application to the iTRAQ data. p-values for testing no difference
of peptide amounts were calculated for all pairs in the pooled iTRAQ con-
trol experiments described in Section 3.3. We used the variance function
h(θ,µ) = exp(θ1 + θ2µ) with θ estimated by the EM algorithm applied to
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Fig. 3. Scatterplots and histograms of p-values for the pooled control experiments ob-
tained by different approaches. Scatterplots are in log scale with dotted lines indicating
significant level of 5% with and without Bonferroni correction.
the pooled data. Three approaches were compared: the naive approach that
replaces µ in h(θ,µ) with Y¯ = (Y1 + Y2)/2, a conservative simple approach
that replaces µ with a, and the approach of Berger and Boos based on (9)
with β = 10−6.
Figure 3 presents scatterplots and histograms of the p-values. Scatter-
plots are depicted in logarithmic scale with dotted lines indicating 0.05 and
0.05/N significant levels. Recall that the null hypothesis holds in these exper-
iments. Two peptides had naive p-values smaller than the Bonferroni cutoff
value, for one of them the Berger and Boos p-value was also under the cutoff
level. For about 40% of the experiments the Berger and Boos p-value was
similar to the conservative p-value, but for the other peptides, the Berger
and Boos method gives considerable smaller values. These are valid p-values
and certainly worth the additional computation effort. The distribution of
p-values under the naive approach is very close to the uniform distribution,
whereas the distributions under the other two approaches are stochastically
larger. This and the simulation presented in the next section suggest that
the naive approach for testing differences of peptide amounts may be only
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slightly anti-conservative, though a more extensive study is required before
the naive approach can be recommended.
As a second application, we calculated p-values for the data described
in Section 3.4 that contrast two mutants found often in certain types of
cancer. There are N = 205 peptides in the data, the p-values of 141, 123 and
9 of them were smaller then 0.05/N according to the naive, the Berger and
Boos and the conservative approach, respectively. These peptides are then
prioritized for in-depth functional characterization.
5. Simulation.
5.1. Estimating the variance function. The performances of the two es-
timation approaches, the MACL and the mixture model, were tested by
simulation under various conditions. The first set of simulations aimed at
testing the performance of the MACL approach. For each of the scenarios
described below, we generated values for the nuisance parameters and then
generated independent pairs of observations from the corresponding normal
distributions. We repeated this process 1000 times for different sample sizes
(N = 200,500,1000 and 2000) and for two different variance functions of the
form exp(θ1+θ2µ): (θ1, θ2) = (5,−1), which is similar to the values obtained
in our data, and (θ1, θ2) = (5,−0.5), which reflects observations with a much
larger variance. The following scenarios were considered:
• Observations fixed: a set of µi values was sampled from the observed Y¯i’s
(with replacement) and the same values were used in all 1000 replications.
• Observations random: a different set of µi values was sampled from the
observed Y¯i’s (with replacement) for each simulation.
• U(8,12): the µi values were generated from the continuous uniform dis-
tribution over (8,12).
• U{8,9, . . . ,12}: the µi values were generated from the discrete uniform
distribution over {8,9, . . . ,12}.
The results of the simulation are summarized in Table 2 and in more
details in the supplemental article [Mandel et al. (2013)]. There seems to
be almost no difference between the scenarios considered (see Table 1 of the
supplementary materials), and this suggests that the approach is insensitive
to modest changes in the distribution of the nuisance parameters. Both the
variance and the bias decrease with sample size for the model (θ1, θ2) =
(5,−1), and the overall performance of the MACL approach for this case is
satisfactory. However, the MACL estimators are biased for the case (θ1, θ2) =
(5,−0.5), and the bias did not decrease with sample size (Table 2). Thus,
unless the variance is very small, the approach is problematic and is not
recommended.
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Table 2
Simulation results for the MACL method under the observations fixed scenario
θ1 θ2
N θ1 bias std θ2 bias std
200 5 −0.061 0.830 −1 0.006 0.081
500 5 −0.051 0.508 −1 0.005 0.049
1000 5 −0.020 0.360 −1 0.002 0.036
2000 5 −0.002 0.251 −1 0.000 0.025
200 5 −1.238 0.759 −0.5 0.127 0.074
500 5 −1.175 0.484 −0.5 0.121 0.047
1000 5 −1.156 0.319 −0.5 0.119 0.031
2000 5 −1.164 0.238 −0.5 0.120 0.023
In order to test the mixture model approach, we generated µi by the ob-
servations fixed scenario under the two variance functions described above.
For each sample size, we simulated 200 data sets and calculated the em-
pirical biases and standard deviations. The results are listed in Table 3. As
expected, the bias and variance of the estimators decrease with sample size
for both models.
Figures 4 and 5 display the performance of the estimators for the variance,
that is, the performance of exp(θˆ1 + θˆ2µ) as a function of µ. The gray lines
are estimated variance functions from 200 simulated data sets and the
true variance function is depicted in black. The figures demonstrate that
the mixture model approach is as good as the MACL in the low variance
case and performs better in the large variance scenario, especially when the
sample size is large.
5.2. Confidence intervals for µ. Intervals for µ based on one observation
use the pivot (Y −µ)2/h(θ,µ) and are exact. Here we study the performance
Table 3
Simulation results for the mixture model method under the observations fixed scenario
θ1 θ2
N θ1 bias std θ2 bias std
200 5 0.580 0.914 −1 −0.071 0.088
500 5 0.423 0.534 −1 −0.049 0.052
1000 5 0.274 0.328 −1 −0.030 0.032
2000 5 0.173 0.227 −1 −0.019 0.022
200 5 0.070 1.026 −0.5 −0.009 0.099
500 5 0.019 0.608 −0.5 −0.003 0.059
1000 5 0.027 0.397 −0.5 −0.003 0.039
2000 5 −0.013 0.291 −0.5 0.001 0.028
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Fig. 4. Estimated variance functions (gray) and the true variance function (black) ob-
tained in 200 simulated data sets for the case (θ1, θ2) = (5,−1). The figures on the left
show the results of the MACL approach and those on the right are for the mixture model
approach. The simulated data sample sizes are, from top to bottom, 200, 500, 1000 and
2000.
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Fig. 5. Estimated variance functions (gray) and the true variance function (black) ob-
tained in 200 simulated data sets for the case (θ1, θ2) = (5,−0.5). The figures on the left
show the results of the MACL approach and those on the right are for the mixture model
approach. The simulated data sample sizes are, from top to bottom, 200, 500, 1000 and
2000.
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Fig. 6. Coverage probability of the naive confidence interval for µ for confidence levels
0.99, 0.95 and 0.90. Solid lines: h(θ,µ) = exp(5−µ), dashed lines: h(θ,µ) = exp(5−0.5µ).
of the corresponding 1−α naive confidence intervals that replace µ with Y
in the variance function h(θ,µ); see Section 3.1.
Figure 6 presents the coverage probability of the naive intervals as a
function of the mean (µ = 7,7.1, . . . ,14), the coverage probability (1− α=
0.9,0.95,0.99) and the variance function [exp(5−µ), exp(5−0.5µ)]. For each
µ, α and variance function h(θ,µ), we estimated the coverage probability by
simulating 100,000 replications from the model N(µ,h(θ,µ)), constructing
naive confidence intervals of level 1− α, and calculating the proportion of
intervals covering µ. The performance depends on the variance at µ, where
the true coverage for small µ (i.e., a large variance) could be much lower
than the aimed coverage, especially for large values of 1 − α and for the
model h(θ,µ) = exp(5− 0.5µ) represented by dashed lines.
5.3. p-values. A third simulation study was conducted with the aim
of understanding the properties of p-values obtained by the different ap-
proaches. For a selected set of values for µ, we generated 10,000 inde-
pendent pairs of observations (Y1, Y2) such that Y1 ∼ N(µ, eθ1+θ2µ) and
Y2 ∼N(µk, eθ1+θ2µk), independently, where µk = µ+ k ×
√
eθ1+θ2µ, that is,
Y1 and Y2 are centered about k standard deviations apart. The parameter
k ranged from 0 to 3, and for (θ1, θ2) we studied the values (5,−1) and
(5,−0.5). We used the value β = 10−3 for the Berger and Boos p-values.
Figures 4 and 5 of the supplemental article [Mandel et al. (2013)] present
the proportions of p-values that were smaller than 0.05 as a function of
µ, k and θ2. For the case θ2 = −1 (supplemental article, Figure 5), the
naive approach is only slightly anti-conservative and only for small values
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of µ, and its power is much larger than that of the other methods. The
Berger and Boos approach works reasonably well only for very small and
very large values of µ; the conservative approach is useless. For the case θ2 =
−0.5 (supplemental article, Figure 4), the naive approach is anti-conservative
for small values of µ with a significant level of up to 0.08 instead of the
declared level of 0.05. However, it is the only method that has a useful
power function.
6. Discussion. This paper presents a protocol for estimating the variance
function of a mass spectrometer when used for relative quantification in pro-
teomic applications. Using two sets of data collected three months apart, we
found that the variance function is stable over time. However, we expect to
find different variance functions in different instruments and, hence, each lab
should estimate the variance parameters of each spectrometer independently
using the protocol described here, and update them periodically. More im-
portantly, the variance estimated here corresponds only to the variance of
the instrument itself, and does not include error terms corresponding to
the natural variability of biological samples or the processing required to
solubilize proteins from cells and tissues, generate peptides, etc.
Two inference approaches are considered. The first estimates the nuisance
parameters by simple averages and then maximizes a target function; the
second approach assumes a mixture model and estimates the variance func-
tion by maximum likelihood. When the variance is small and changes slowly
as a function of the mean, as is the case in the data we analyzed, an average
of two iTRAQ reporter ions per peptide provides a reasonable estimate for
the unknown µ and the first approach gives good results. However, it may
yield highly biased estimators in other scenarios, as demonstrated by simu-
lations, and we therefore recommend the routine use of the mixture model
approach that has a sound theoretical justification.
When using the estimated variance function for statistical inference on
one parameter µ, exact methods for constructing confidence intervals are
available and are much more appropriate than intervals constructed by the
anti-conservative naive approach. On the other hand, for inference on the
difference or the ratio of peptide abundance measured across two biological
conditions, the naive approach performs quite well, yielding a significant
level only slightly larger than the aimed one.
The iTRAQ protocol is somewhat more complicated than presented here,
as it involves preprocessing of the spectral data to correct for differences
in total protein amount, iTRAQ label purity and instrument-specific pa-
rameters. Moreover, iTRAQ is known to suffer from contamination due to
co-eluting chromatographic peaks that also share similar precursor masses
(i.e., peptides which have a similar m/z value and retention time). Theoret-
ically, these factors may induce dependence between measurements that is
ignored in the current analysis.
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In order to test the underlying normal assumption, Zhang et al. produced
a q–q plot of (Yi1 − Yi2)/
√
h(θˆ, Y¯i) that showed a very good fit. Although
the graph is suggestive, it relies on Y¯i as an estimate for the nuisance pa-
rameter µi, hence it does not have a theoretical support. A formal approach
we intend to explore requires at least three observations for each peptide.
A simple transformation of each of the triplets results in variables that, un-
der the normal model, have a Cauchy distribution, and a q–q plot or formal
goodness-of-fit tests can be easily employed. This approach requires iTRAQ
data from a control experiment that yields more than two independent and
identically distributed measures for each peptide. We intend to conduct such
an experiment in the future.
The conservative results of the exercise conducted in Section 3.2 are par-
tially due to the inherently conservative construction of the intervals, but
may also be a result of the special parametric shape for the variance func-
tion we considered. Our chosen parametric model is very simple, enabling
the implementation of simple algorithms, and is supported quite well by the
data. A nonparametric method has been recently suggested for the analysis
of microarray data [Carroll and Wang (2008)]; the possibility of adopting
this method to MS data and of using it for goodness-of-fit testing should be
further explored.
APPENDIX A: BIAS OF THE ESTIMATING EQUATIONS
Recall that Y¯i ∼N(µi, 12eθ1+θ2µi) and S2i ∼ eθ1+θ2µiχ2(1), and that Y¯i and
S2i are independent. Straightforward calculations show that E(S
2
i ) = e
θ1+θ2µi
and E{exp(−θ1− θ2Y¯i)}= exp(−θ1 − θ2µi+ 14θ22eθ1+θ2µi) and, therefore,
E
{
N−1
N∑
i=1
S2i exp(−θ1 − θ2Y¯i)
}
=N−1
N∑
i=1
exp
(
1
4
θ22e
θ1+θ2µi
)
so that the expectation of the first equation (4) differs from zero, unless
θ2 = 0, that is, the homogeneous model of Neyman and Scott (1948).
For the second equation, we have EY¯i exp(−θ2Y¯i) =− ddtE exp(−tY¯i)|t=θ2 =
− ddt exp{−tµi + t2 14eθ1+θ2µi}|t=θ2 = (µi − 12θ2eθ1+θ2µi) exp{−θ2µi + θ22 14 ×
eθ1+θ2µi}, so that E{Y¯iS2i exp(−θ1 − θ2Y¯i)} = (µi − 12θ2eθ1+θ2µi) exp(14θ22 ×
eθ1+θ2µi), and the expectation of the left-hand side of (5) is
N−1
N∑
i=1
µi−N−1
N∑
i=1
(
µi − 1
2
θ2e
θ1+θ2µi
)
exp
(
1
4
θ22e
θ1+θ2µi
)
,
which again differs from 0 for θ2 6= 0.
In general, the bias will be small if eθ1+θ2µi is small for all i, which means
that the variance of the measurements is small and, hence, the local averages
are good estimators for the unknown µi parameters.
VARIANCE FUNCTION ESTIMATION IN QUANTITATIVE MS 21
APPENDIX B: CONSISTENCY OF THE MLE
A generic sample point is y = (y1, y2), where, by conditional independence,
f(y; θ|µ) = {2πh(θ,µ)}−1 exp
{
−(y1 − µ)
2 + (y1 − µ)2
2h(θ,µ)
}
.(10)
The marginal density of Y = (Y1, Y2) is g(y; θ,G0) =
∫
t f(y; θ|t)dG0(t).
The proof of consistency is based on the result of Kiefer and Wolfowitz
(1956) (KW hereafter); the metric we use below is given in KW equa-
tion (2.2).
We complete the parameter space of (θ,G0) by including all proper dis-
tributions functions with support in [a, b].
Assumption 1 of KW trivially holds with respect to the Lebesgue measure.
Next, note that f(y; θ|µ), and hence g(y; θ,G0), is bounded above by α−1.
Let (θi,Gi)→ (θ∗,G∗), where (θ∗,G∗) is in the complete parameter space.
In order to verify Assumption 2 of KW, we need to show that g(y; θi,Gi)→
g(y; θ∗,G∗). We have
|g(y; θi,Gi)− g(y; θ∗,G∗)|
=
∣∣∣∣
∫
f(y; θi|t)dGi(t)−
∫
f(y; θ∗|t)dG∗(t)
∣∣∣∣
≤
∣∣∣∣
∫
{f(y; θi|t)− f(y; θ∗|t)}dG∗(t)
∣∣∣∣+
∣∣∣∣
∫
f(y; θi|t)d(Gi(t)−G∗(t))
∣∣∣∣
≤
∫
|f(y; θi|t)− f(y; θ∗|t)|dG∗(t) +α−1
∫
d|Gi(t)−G∗(t)|.
The first term vanishes by the Dominated Convergence theorem and the
second vanishes by the convergence of Gi to G
∗.
For verifying Assumption 3 of KW, define m(y; θ∗,G∗, ρ) = supg(y; θ,G),
where the supremum is taken over all (θ,G) such that |θ−θ∗|+ |G−G∗|< ρ.
We need to show that m is a measurable function of y for any ρ > 0 and
any (θ∗,G∗) in the complete parameter space. This is true for the same
arguments given by KW in their first example: g is for each y continuous in
(θ,G) and the parameter space is separable. To show this formally, define
A(θ∗,G∗, ρ, c) = {y :m(y; θ∗,G∗, ρ)> c}, and let {(θi,Gi)} and {yj} be dense
subsets in the parameter and sample space, respectively. Let B(y, r) and
B(θ,G, r) be balls of radius r around the corresponding points, then
A(θ∗,G∗, ρ, c) =
∞⋂
n=1
⋃
j
B(yj,1/n),
where the union is over {j :∃(θi,Gi) ∈B(θ∗,G∗, ρ) such that g(yj ; θi,Gi)> c}.
Assumption 4 of identification follows from Bruni and Koch [(1985), The-
orem 1], that proves that G0 and h(θ,µ) are identifiable on the support of µ.
Assumption (iii) below equation (6) ensures identifiability of θ.
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To verify Assumption 5, note that our assumptions on h(θ,µ) guarantee
that g(y; θ,G) is bounded above and below so that E log{g(Y ; θ,G)}>−∞,
where the expectation is taken with respect to g(y; θ0,G0), the true density
of Y .
APPENDIX C: AN EM ALGORITHM
Let f(y; θ|µ) be the bivariate normal density defined in (10), and let
a≤ µ1 ≤ · · · , µJ ≤ b be fixed scalars (support points of G0). We approximate
the likelihood of one observed pair by the following discrete mixture model:
g(y; θ,pi) =
J∑
j=1
πjf(y; θ|µj),(11)
where pi = (π1, . . . , πJ), πj ≥ 0 and π1 + · · ·+ πJ = 1. The unknown param-
eters are the πj ’s and θ.
To construct the EM algorithm, consider a Multinomial variable ∆ over
1, . . . , J with a probability vector pi, and define (δ1, . . . , δJ) by δj = I{∆= j},
where I is the indicator function. Let Y = (y1, . . . , yN) be data on N pairs,
then the complete log likelihood can be written as
ℓ(pi, θ;Y ) =
N∑
i=1
J∑
j=1
δij log{f(yi; θ|µj)}+
N∑
i=1
J∑
j=1
δij log(πj),(12)
where δij is an indicator for the (unobserved) event {pair i has mean µj}.
Denote by old the current estimates of the unknown parameters, then,
using the Bayes formula, the expectation step reduces to estimating
Eold(δij |Y ) = Eold(δij |yi) = P old(δij = 1|yi)
=
πoldj f(yi; θ
old|µj)∑J
k=1 π
old
k f(yi; θ
old|µk)
=:woldij .
Note that
∑J
j=1 δij = 1 by definition, so the above formula can be interpreted
as the current estimate of the probability that yi was generated by the
distribution having mean µj .
The maximization step is obtained by replacing δij in (12) with w
old
ij and
solving
max
pi,θ
N∑
i=1
J∑
j=1
woldij log{f(yi; θ|µj)}+
N∑
i=1
J∑
j=1
woldij log(πj),(13)
which is done separately for pi and θ. For θ, the problem is of a nonparametric
regression type and can be solved by reweighted least squares, similar to the
MACL approach. The mixing probabilities are simply updated by
πnewj =
1
N
N∑
i=1
woldij .
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SUPPLEMENTARY MATERIAL
Web-based supplementary materials variance function estimation in quan-
titative mass spectrometry with application to iTRAQ labeling
(DOI: 10.1214/12-AOAS572SUPP; .pdf). Section A: Workflow of the iTRAQ
technique. Section B: Estimate of G0. Section C: Sensitivity of the EM al-
gorithm to initial values. Section D: Detailed simulation results.
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